Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06138106 · ClinicalTrials.gov registry record · NA
Developing a Nutritional Supplement to Increase Collagen Synthesis in People
A NA study of Exercise and Dietary Supplements, sponsored by University of California, Davis.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06138106: Recruiting NA study of Exercise and Dietary Supplements, sponsored by University of California, Davis.
NCT06138106 is a NA study of Exercise and Dietary Supplements that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 20 participants, below the 8,910-participant average among 57 other Exercise trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06138106, a NA study of Exercise and Dietary Supplements, is actively recruiting participants, sponsored by University of California, Davis.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test whether a natural product supplement can potentiate the increase in collagen synthesis following the ingestion of collagen protein. The investigators have developed a model of natural (GRAS certified) products that stimulate collagen synthesis, in vitro. The investigators will determine whether the natural product supplement can potentiate the collagen synthetic response to the ingestion of collagen protein. Basal and fed serum will be isolated and these samples will be used to treat human engineered ligaments.
Primary Outcome
Collagen protein synthesis will be indirectly measured by measuring pro-collagen type I N-terminal propeptide (PINP) in the serum before and 4 hours after the last exercise bout (at day 7 of the protocol).
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Natural Product Supplement
- DIETARY_SUPPLEMENT Placebo control
Study Locations (1)
California
- Hickey Laboratory - Davis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2023-11-21 |
| Est. Completion | 2026-06-01 |
| Phase | NA |
What NCT06138106 shows while recruiting
NCT06138106 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 8,910-participant average among 57 other Exercise trials with a reported enrollment target (100% lower).
The record links to 3 conditions, with Exercise appearing as the primary indexed condition, and to 2 interventions - of which Natural Product Supplement is the first listed.
NCT06138106 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06138106 about?
NCT06138106 is a clinical study titled "Developing a Nutritional Supplement to Increase Collagen Synthesis in People". The purpose of this study is to test whether a natural product supplement can potentiate the increase in collagen synthesis following the ingestion of collagen protein. The investigators have developed a model of natural (GRAS certified) products that stimulate collagen synthesis, in vitro. The inve...
What is the current status of trial NCT06138106?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2023-11-21. Estimated completion is 2026-06-01.
What conditions does trial NCT06138106 study?
This clinical trial studies the following conditions: Exercise, Dietary Supplements, Connective Tissue.
What interventions are being tested in trial NCT06138106?
The interventions under investigation include: Natural Product Supplement (DIETARY_SUPPLEMENT), Placebo control (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06138106?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06138106 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Exercise
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06138106's enrollment target sits among peer trials
20 50th of 57 higher than 5 of 57 other Exercise trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Exercise trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Goal Setting to Promote Physical Activity Adherence in Midlife Adults
RECRUITING · NA
-
Better Lifestyle Counseling for African American Women During Pregnancy
RECRUITING · NA
-
Postnatal Exercise to Activate Baby's Brown Fat
RECRUITING · NA
-
GENESIS: Genotype Guided - Natriuretic Peptides - Cardiometabolic Health Study
RECRUITING · NA
-
The VESPA Pilot Study
RECRUITING · NA
-
Time to Move in Pregnancy Hyperglycemia
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI